MindWalk Holdings (HYFT) EBIT (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly EBIT came in at -$3.2 million in Q2 2026, up 74.41% year-over-year from -$1.8 million in Q2 2025, and down 19.29% quarter-over-quarter from -$2.6 million in Q1 2026.
Analysis
MindWalk Holdings (HYFT) EBIT (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported EBIT for 7 consecutive years, with -$3.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBIT rose 74.41% year-over-year to -$3.2 million in Q2 2026; TTM through Apr 2026 was -$10.8 million, a 99.7% increase from a year earlier, with the FY2026 full-year figure at -$10.8 million, up 59.14% from the prior year.
- EBIT was -$3.2 million for Q2 2026 at MindWalk Holdings, down from -$2.6 million in the prior quarter.
- Over five years, EBIT peaked at -$2.0 million in Q4 2025 and troughed at -$5.1 billion in Q3 2023.
- A 5-year average of -$724.0 million and a median of -$3.9 million in 2023 frame the typical range for EBIT.
- Across the five-year window, EBIT plunged 72164.45% in 2023 and jumped 99.93% in 2024, its largest moves.
- Over 5 years, EBIT stood at -$5.9 million in 2022, then sank by 72164.45% to -$4.3 billion in 2023, then jumped by 99.93% to -$3.0 million in 2024, then jumped by 32.62% to -$2.0 million in 2025, then sank by 57.87% to -$3.2 million in 2026.
- The last three EBIT figures came in at -$3.2 million (Q2 2026), -$2.6 million (Q1 2026), and -$2.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 506.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 146.82 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 119.89 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 137.83 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 14.80 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -58.55 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | -522,000.00 |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -3.16 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | -2.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -3.16 Mn |
| Jan 31, 2026 | -2.65 Mn |
| Oct 31, 2025 | -2.00 Mn |
| Jul 31, 2025 | -3.03 Mn |
| Apr 30, 2025 | -12.34 Mn |
| Jan 31, 2025 | -17.51 Mn |
| Oct 31, 2024 | -2.97 Mn |
| Jul 31, 2024 | -3.56 Bn |
| Apr 30, 2024 | -16.47 Mn |
| Jan 31, 2024 | -2.47 Mn |
| Oct 31, 2023 | -4.26 Bn |
| Jul 31, 2023 | -5.13 Bn |
| Apr 30, 2023 | -4.49 Mn |
| Jan 31, 2023 | -3.40 Mn |
| Oct 31, 2022 | -5.89 Mn |
| Jul 31, 2022 | -7.81 Mn |
| Apr 30, 2022 | -3.38 Mn |
| Jan 31, 2022 | -2.63 Mn |
| Oct 31, 2021 | -3.56 Mn |
| Jul 31, 2021 | -2.82 Mn |